Eilika Weber-Ban Lab
@ewb-lab.bsky.social
180 followers
220 following
14 posts
We study proteostasis and cellular degradation machines in mycobacteria.
weber-ban-lab.ethz.ch
Posts
Media
Videos
Starter Packs
Reposted by Eilika Weber-Ban Lab
Reposted by Eilika Weber-Ban Lab
Reposted by Eilika Weber-Ban Lab
Reposted by Eilika Weber-Ban Lab
Eilika Weber-Ban Lab
@ewb-lab.bsky.social
· May 15
Reposted by Eilika Weber-Ban Lab
Eilika Weber-Ban Lab
@ewb-lab.bsky.social
· Apr 22
Combating vaccine revisionism - Nature Medicine
The scientific community must take a strong and active stand against vaccine revisionism — the false narrative that there is insufficient evidence to support the safety and efficacy of vaccines.
www.nature.com
Eilika Weber-Ban Lab
@ewb-lab.bsky.social
· Mar 28
Substrates bind to residues lining the ring of asymmetrically engaged bacterial proteasome activator Bpa - Nature Communications
Mycobacterium tuberculosis has a proteasome similar to eukaryotes. This study reveals how the activator Bpa recruits its substrate HspR, providing structural and mechanistic insights. The authors iden...
www.nature.com
Reposted by Eilika Weber-Ban Lab
Reposted by Eilika Weber-Ban Lab
ETH Zurich
@ethz.ch
· Mar 6
Fundamental and applied research are two sides of the same coin
Annette Oxenius has been appointed ETH Vice President for Research. From 1 August 2025, she will assume responsibility for research development and promotion at ETH Zurich. The 56-year-old Swiss natio...
ethz.ch
Eilika Weber-Ban Lab
@ewb-lab.bsky.social
· Feb 25
Structural basis for the midnolin-proteasome pathway and its role in suppressing myeloma
The midnolin-proteasome pathway degrades many nuclear proteins without ubiquitination, but how it operates mechanistically remains unclear. Here, we present structures of the midnolin-proteasome compl...
www.biorxiv.org
Reposted by Eilika Weber-Ban Lab